MSN Laboratories
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Abiraterone | Abiraterone | 2019-07-10 | 2027-2038 | |
| Albendazole | Albendazole | 2021-01-21 | ||
| Aminocaproic acid | Aminocaproic acid | 2020-11-06 | — | |
| Atorvastatin | Atorvastatin | 2019-02-08 | 2037 | |
| Bortezomib | Bortezomib | 2022-07-26 | 2032-2042 | |
| Bumetanide | Bumetanide | 2022-08-04 | ||
| Capecitabine | Capecitabine | 2018-07-02 | ||
| Chlorpromazine | Chlorpromazine | 2022-01-27 | ||
| Clobazam | Clobazam | 2021-05-11 | 2024-2040 | |
| Clofarabine | Clofarabine | 2017-12-06 | ||
| Decitabine | Decitabine | 2019-08-28 | 2028-2030 | |
| Deferasirox | Deferasirox | 2019-11-20 | 2034 |
1
2
3
4
5
6
>
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use